We also found that inhibition of PRMT5, MEP50, or WDR5 strongly decreased the abundance of H3K4me3 and Polymerase II on the ANGPT2 promoter in HCC cells (Fig. 6E). Here, PRMT5 is linked to hepatocellular carcinoma.